Ermenegildo Zegna NV
ZGN
德康醫療
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
美股市場個股詳情
CRNX Crinetics
- 53.600
- +0.860+1.63%
收盤價 12/20 16:00 (美東)
- 53.600
- 0.0000.00%
盤後 16:00 (美東)
49.71億總市值-14.49市盈率TTM
54.250最高價51.730最低價194.05萬股成交量52.280今開52.740昨收1.04億成交額2.12%換手率虧損市盈率(靜)9273.76萬總股本62.53052周最高5.97市淨率49.03億流通值33.67052周最低--股息TTM9146.58萬流通股62.530歷史最高--股息率TTM4.78%振幅10.630歷史最低53.517平均價1股每手
關於Crinetics公司
Crinetics Pharmaceuticals Inc 是一家臨牀階段的製藥公司，專注於罕見內分泌疾病和內分泌相關腫瘤的新療法的發現、開發和商業化。
公司介紹
公司代碼CRNX
公司名稱Crinetics
上市日期2018/07/18
發行價格17.00
成立日期2008
CEODr. R. Scott Struthers, PhD
所屬市場納斯達克
員工數量290
年結日12-31
公司地址6055 Lusk Boulevard
城市San Diego
省份加利福尼亞州
國家美國
郵編92121
電話1-858-450-6464
董事高管
- 姓名
- 職務
- 年薪
- Dr. R. Scott Struthers, PhD
- Director, President and Chief Executive Officer
- 574.80萬
- Dr. Dana Pizzuti, M.D.
- Chief Medical and Development Officer
- --
- Marc J.S. Wilson
- Chief Financial Officer and Principal Accounting Officer
- 251.35萬
- Dr. Stephen F. Betz, PhD
- Chief Scientific Officer
- 249.69萬
- Jeff E. Knight
- Chief Operating Officer
- 236.24萬
- Isabel Kalofonos
- Chief Commercial Officer
- --
- Dr. Wendell D. Wierenga,PhD
- Chairman of the Board
- 37.53萬
- Dr. Weston Nichols, PhD
- Independent Director
- 33.86萬
- Stephanie S. Okey, M.S.
- Independent Director
- 34.23萬
- Caren Deardorf
- Independent Director
- 33.01萬
- Matthew K. Fust
- Independent Director
- 34.86萬
- Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D.
- Independent Director
- 33.86萬
- Dr. Camille L. Bedrosian,M.D.
- Independent Director
- 33.96萬
- Dr. Alan Krasner,M.D.
- Chief Endocrinologist
- 216.26萬